Intervention
Blood Collection
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 17 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
17 shownPositron Emission Tomography (PET) Imaging of ThrombosisNCT03830320 · 2016-04-01
RECRUITINGGenetics Of Autoimmunity In Type I DiabetesNCT03648918 · 2001-08-01
RECRUITINGEvaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With CancerNCT07781852 · 2026-09-01
NOT_YET_RECRUITINGBiological Sample Repository for Gastrointestinal DisordersNCT05874726 · 2023-07-19
ACTIVE_NOT_RECRUITINGabioSCOPE IgE Assay to Aid in the Diagnosis of AllergiesNCT04442932 · 2020-11-15
WITHDRAWNAnalytical Validation of the abioSCOPE Device With an IgE Test Panel: Point-of-Care Precision, Sample Type Comparison and Method CorrelationNCT04401631 · 2020-11-01
WITHDRAWNMetabolic and Microbial Profiling of Lung CancerNCT03998189 · 2019-10-11
TERMINATEDTaxane Induced Peripheral Neuropathy in Chinese Patients With Breast CancerNCT04068090 · 2019-08-23
UNKNOWNAssessment of ProEnkephalin to Detect Acute Kidney Injury (AKI)NCT04019314 · 2019-06-11
COMPLETEDGenetics and Heart Health After Cancer TherapyNCT03510689 · 2017-12-05
COMPLETEDIs There Any Relation Between Serum Anti-p53 Antibody and TLG, MTV and SUV as PET Parameters in Lung Cancer Patients?NCT02309567 · 2014-05-01
COMPLETEDAssessment of Paclitaxel-Induced NeuropathyNCT01953159 · 2013-08-29
ACTIVE_NOT_RECRUITINGSurveillance Markers of Utility for Recurrence After Neoadjuvant Chemotherapy for Breast CancerNCT02830282 · 2013-07-01
COMPLETEDCardiotoxicity of Cancer Therapy (CCT)NCT01173341 · 2010-07-01
ENROLLING_BY_INVITATIONAromatase Inhibitor-Associated Musculoskeletal Symptoms in Non-Metastatic, Post Menopausal Breast Cancer PatientsNCT01051609 · 2010-05-01
COMPLETEDLetrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by SurgeryNCT00651976 · 2008-03-01
TERMINATEDPredicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast CancerNCT00537173 · 2007-09-01
TERMINATEDCommon conditions
Breast Cancer9Cancer3Allergic Asthma2Allergy2Allergy Cockroach2Allergy to Cats2Allergy to House Dust2Diabetes Mellitus2Ovarian Cancer2Allergy Mold1Allergy to Dog Dander1Allergy to Dog Dander (Finding)1Atrial Fibrillation1Bladder Cancer1Colorectal Cancer1COVID-191Decompensated Heart Failure1Diabetes Mellitus, Type 11Diabetes Mellitus, Type 21Diabetes Type 21Drug-Induced Cardiomyopathy1Esophageal Cancer1Gastric Cancer (GC)1Gastro-Intestinal Disorder1Gastroesophageal Reflux1
Leading sponsors
Abramson Cancer Center at Penn Medicine
3
Abionic SA
2
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
1
Cumhuriyet University
1
Hoosier Cancer Research Network
1
Jonsson Comprehensive Cancer Center
1
Lumina Pharmaceuticals Inc
1
Massachusetts General Hospital
1
Mayo Clinic
1
Medical College of Wisconsin
1
Pichamol Jirapinyo, MD, MPH
1
University of Chicago
1
Vanderbilt-Ingram Cancer Center
1
Wake Forest University Health Sciences
1
Trial status mix
COMPLETED5
TERMINATED3
ACTIVE_NOT_RECRUITING2
RECRUITING2
WITHDRAWN2
ENROLLING_BY_INVITATION1
NOT_YET_RECRUITING1
UNKNOWN1
Phase mix
EARLY_PHASE12
NA2
PHASE11
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.